James Chmiel is a Professor of Pediatrics in the Division of Pediatric Pulmonology and Allergy/Immunology at Case Western Reserve University School of Medicine and Rainbow Babies and Children's Hospital. Dr. Chmiel received his B.S. from the University of Notre Dame and his M.D., M.P.H. from the University of Michigan. He completed his pediatrics residency at Children's Memorial Hospital/Northwestern University Medical School, and his Pediatric Pulmonology Fellowship at Rainbow Babies and Children's Hospital/Case Western Reserve University School of Medicine, where he has been on faculty since 1998. Currently, he is the Director of the Pediatric Program of the Cystic Fibrosis (CF) Care Center, and the Director of the CF Foundation Therapeutics Development Center. Dr. Chmiel's research involves understanding the inflammatory response of the lung, particularly as it relates to CF and asthma, and the impact of anti-inflammatory therapeutics upon that response. He has published several papers in both areas. In addition to investigator initiated studies, Dr. Chmiel has participated in several clinical trials networks including AsthmaNet, SARP 3, Inner City Asthma Consortium I, and the CF Foundation's Therapeutics Development Network. Dr. Chmiel is the Chair of the CF Foundation's Anti-Inflammatory Working Group, and a member of the CF Foundation's Clinical Research Committee. Dr. Chmiel is currently is the Immediate Past-Chair of the Pediatrics Assembly of the American Thoracic Society. In 2014, Dr. Chmiel began serving on the Pediatric Pulmonology sub-board of the American Board of Pediatrics. He became the President of that Sub-board in January 2017.